Company Filing History:
5 out of 3,540 
3 out of 4 Years Active: 2017-2022
Title: Innovations and Contributions of Inventor Karin Bok
Introduction
Karin Bok is a prominent inventor based in Bethesda, MD (US), known for her significant contributions to the field of biotechnology. With a total of five patents to her name, she has made remarkable advancements in the development of monoclonal antibodies targeting noroviruses.
Latest Patents
Karin Bok's latest patents include "Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use." This patent discloses isolated VH monoclonal antibodies that specifically bind to a Norovirus polypeptide. The Norovirus can be a Genogroup I or Genogroup II Norovirus, including strains such as Norwalk or MD2004 virus. The monoclonal antibodies are designed to specifically bind to the VP1 protein. Additionally, the patents cover compositions that include these antibodies, nucleic acids encoding them, expression vectors, and isolated host cells that express the nucleic acids. These innovations can be utilized for detecting the presence of Norovirus in biological samples and for treating or preventing Norovirus infections.
Career Highlights
Throughout her career, Karin Bok has worked with notable organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services and the Instituto Nacional De Technologia Agropecuaria. Her work has significantly impacted public health and the understanding of viral infections.